Cocrystal Pharma (COCP) Capital Expenditures (QoQ) (2010 - 2024)
Cocrystal Pharma (COCP) Capital Expenditures (QoQ) (2010 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Cocrystal Pharma | 12.57 Mn | 7.74 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -86.44% |
| Jun 30, 2023 | -68.89% |
| Mar 31, 2023 | 275.00% |
| Dec 31, 2021 | 100.00% |
| Sep 30, 2021 | -73.33% |
| Jun 30, 2021 | -40.00% |
| Mar 31, 2021 | 2,400.00% |
| Dec 31, 2020 | -94.74% |
| Sep 30, 2020 | -85.04% |
| Jun 30, 2020 | 36.56% |
| Mar 31, 2020 | 9,200.00% |
| Dec 31, 2019 | -99.13% |
| Sep 30, 2019 | 2,775.00% |
| Jun 30, 2019 | -84.00% |
| Mar 31, 2019 | 66.67% |
| Dec 31, 2018 | 87.50% |
| Jun 30, 2017 | -78.79% |
| Mar 31, 2017 | 1,550.00% |
| Dec 31, 2016 | -84.62% |
| Sep 30, 2016 | -27.78% |